BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

World

Biocon Biologics Secures Market Access for Bmab 1200 in Europe, UK, Canada, and Japan Through Janssen Settlement

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and a subsidiary of Biocon Ltd , announced that the Company has signed a settleme...

August 29, 2024 | News

GenScript Launches "GenTeer" Volunteer Platform, Pioneering Global Philanthropy with a Focus on ESG Impact

GenScript Biotech Corporation (referred to as GenScript) officially launched the "GenTeer (GenScript Volunteer) Program," an innovative global philanthropy...

August 21, 2024 | News

Angiex Initiates Patient Dosing in Phase 1 Clinical Trial of AGX101, a First-in-Class TM4SF1-Directed Antibody-Drug Conjugate for Solid Cancers

Angiex, a developer of Nuclear-Delivered Antibody-Drug Conjugate™ (ND-ADC) therapies for solid cancers, announced that patient dosing has begun for t...

August 12, 2024 | News

OmniAb CEO Matt Foehr Confident in 2024 Growth Potential Following Strong Q2 Performance

OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and six months ended June 30, 2024, and provided operating and partner prog...

August 09, 2024 | Company results

Andelyn Biosciences Partners with Broad Institute to Enhance Gene Therapy Platform with MyoAAV Plasmids

Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has entere...

August 07, 2024 | News

Agilent Acquires BIOVECTRA for $925 Million, Expanding Biopharma Capabilities

Agilent Technologies Inc. announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturing...

July 23, 2024 | News

Merck Group Announces Acquisition of UnitySC for €155 Million

This strategic acquisition is a significant milestone in Merck’s Electronics business, aimed at expanding its capabilities and strengthening ...

July 18, 2024 | News

CordenPharma Announces €900 Million Investment to Expand Peptide Manufacturing Capabilities in US and Europe

CordenPharma has announced its largest strategic investment to date with a committed spend of ~€900m over the next 3 years to grow its Peptide technol...

July 17, 2024 | News

Monod Bio Unveils LuxSit™ Pro: World's First Commercial De Novo Luciferases for Research and Diagnostics

Monod Bio, a life sciences company using AI to generate new proteins for the research use only (RUO) and in vitro diagnostics (IVD) markets, announce...

July 16, 2024 | News

Thermo Fisher Completes $3.1 Billion Acquisition of Olink Holding AB

Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, announced that it has completed its acquisiti...

July 11, 2024 | News

Eppendorf Award for Young European Investigators 2024 goes to Clemens Plaschka, Austria

Clemens Plaschka, born 1989, receives the 20,000 euro award for his research on the molecular machines that generate and export messenger&nbs...

July 04, 2024 | News

HiRO Acquires DeltaMed Solutions, Expands Across 10 Countries

Harvest Integrated Research Organization (HiRO), a full-service, boutique global CRO, is excited to announce its latest strategic move with the successful ...

July 02, 2024 | News

Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer

Renowned, experienced industry leader in newly created role for Cytiva Ruffieux joins Cytiva executive team on 1 July 2024 Cytiva is strength...

June 28, 2024 | News

Ochre Bio and GSK Enter Multi-Year Partnership to Advance Liver Disease Research

Ochre Bio, a pioneer in chronic liver disease medicine development, has today announced the start of a multi-year data licence agreement with GSK. The part...

June 13, 2024 | News

Stay Connected